Theranostics 2018, Vol. 8, Issue 19 5289 Ivyspring International Publisher Theranostics 2018; 8(19): 5289-5306. doi: 10.7150/thno.28228 Research Paper MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance Jinping Lu1,3*, Yuejin Li1*, Yuanzhong Wu2,*, Shan Zhou1, Chaojun Duan1, Zigang Dong4, Tiebang Kang2, Faqing Tang1,3 1. Department of Clinical Laboratory, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, 410013, Changsha, China 2. State Key Laboratory of Oncology in South China and Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong, China 3. Department of Clinical Laboratory and Medical Research Center, Zhuhai Hospital, Jinan University, Zhuhai 519000, Guangdong, China 4. Hormel Institute, University of Minnesota, 801 16th Avenue NE, Austin, MN 55912 *Lu J, Li Y, and Wu Y contributed equally to this work. Corresponding authors: Dr. Faqing Tang, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, 410013, Changsha, China. E-mail:
[email protected]; Tel.: 86-731-89762688; Fax: 86-731-89762688; Dr. Tiebang Kang, State Key Laboratory of Oncology in South China and Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong, China. E-mail:
[email protected]. © Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2018.07.01; Accepted: 2018.09.17; Published: 2018.10.22 Abstract Molecule interacting with CasL2 (MICAL2), a microtubule-associated monooxygenase, is highly expressed in various cancers and is involved in cancer pathogenesis, but the mechanisms underlying its regulation in carcinogenesis are unclear.